The Heart Failure Policy Network

arrow-splash

Helping advance meaningful policy change on heart failure

The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from Novartis Pharma and Vifor Pharma. Additional support for The handbook launch in September 2018 has been provided by Bayer AG. The content produced by the Network is not biased to any specific treatment or therapy, and is endorsed and owned by the Network’s members, who have full editorial control. All members provide their time for free.

#HeartFailiure is the single highest cause for hospitalisation in people over the age of 65. By putting more focus on this condition we can improve the lives of millions while improving #healthcare systems. #ChangeHFpolicy bit.ly/HF-Handbook pic.twitter.com/COeJW7lVRB